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GRANULOSA AND THECA CELL TUMORS OF THE OVARY
JOHN N . CANTON, M.D.*

AND C . PAUL HODGKINSON,

M.D.*

Credit for the first description of granulosa cell tumor is given to von Werdt'
and to Loeffler and PrieseF for thecoma. Collectively these tumors are known as
feminizing mesenchymomas. More than 1100 granulosa cell and 300 theca cell
tumors have been reported in the world literature. Age incidence is wide. A thecoma
was removed from a woman aged 92 years and bilateral granulosa cell tumors from
an infant aged 14 weeks. About 50% of granulosa cell tumors and 40% of thecomas
occur before the menopause. Approximately 5% of granulosa cell tumors are seen
in the pre-pubertal age group; however, thecomas are rare before the age of 30.
Only 3 thecomas have been reported before the age of 10 and one of these in a
patient under one year.
Classifications of ovarian tumors often list both granulosa cell and theca cell
tumors as "functioning tumors", and some authors have reported between 60%
and 95% as functional.^-'' However, in many instances, no "functioning" influence
is present. In most cases the clinical parameter of function was estrinism; but
rare cases have shown virilism. Depending on the age group, the earliest symptom
may be precocious pseudo-puberty, menorrhagia, or postmenopausal bleeding. On
physical examination an adnexal mass may be felt, but no statistics are available
which show the percentage of these tumors to be palpable. Abnormal uterine
bleeding incidental to the tumor is often associated with hyperplastic endometrium.
Some authors'-' report an increased incidence of endometrial carcinoma in patients
with granulosa cell tumor of the ovary. If in a patient with postmenopausal bleeding
the first and second dilatation and curettage yields endometrium which is hyperplastic, a repeated episode of bleeding would suggest the need of laparotomy even
in the absence of positive pelvic findings.
Recent publications'-" list the incidence of malignancy of granulosa cell tumor
as 10% or more. The degree of malignancy of the tumor is difficult to predict even
by histologic appearance. Each granulosa cell tumor should be considered potentially
malignant and a thorough microscopic examination done. Only 10 cases of malignant
thecomas are reported in the literature.
The granulosa cell tumor is usually unilateral and solid and varies in size from
a few millimeters to 34 pounds. It may be cystic, hemorrhagic and variable in color.
Microscopically the pattern is cylindromatous, microfollicular with Call-Exner bodies
(Fig. 1) sarcomatous or undifferentiated. Grossly, thecomas appear similar to
fibromas or leiomyomas. Microscopically they show fibrous and thecal elements
and may require fat stains to differentiate them from the fibromas. Luteomas may
be included here since Novak and others consider them lutinized granulosa-theca
cell tumors and not a separate class.
Treatment depends upon the age of the patient. I f in the prepubertal patient
the tumor is bilateral, or unilateral and locally invasive, removal of both adnexae
and uterus is indicated. I f the tumor is unilateral and non-invasive a unilateral
''Division of Gynecology and Obstetrics.
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Figure 1
Granulosa cell tumor with Call-Exner bodies.

oophorectomy is acceptable provided the patient is carefully and frequently followed.
The patient in the menstrual age group presents a greater problem. Formerly,
it was suggested that if the tumor was unilateral and non-invasive it was permissable
to save the uterus and opposite ovary, depending upon the patient's desire for more
children. Because of recurrence even when the tumor is non-invasive, confined
to one ovary, and apparently benign conservatism based on age or child-bearing
potential should not be considered, and patients in this group should have bilateral
oophorectomy and hysterectomy.
In the postmenopausal patient, regardless of one or both ovary involvement,
bilateral oophorectomy and hysterectomy are indicated. Radiation is best reserved
for patients in whom invasion or recurrence is proved. Granulosa cell tumors
319
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have been known to recur 22 years following surgery and may respond well to
radiation. Treatment of thecomas is the same as for any benign unilateral ovarian
lesion unless malignancy upon microscopic examination is shown. Patients with
either type of tumor should be closely followed for the rest of their lives.
CASE DISCUSSION
This report is of 17 patients, three of whom present unusual features. The
earliest symptoms included some form of abnormal uterine bleeding in six of the
ten patients with granulosa cell tumors and four of the seven with thecomas. A
definite pelvic mass was present preoperatively in only seven of the 17. Total
hysterectomy and bilateral salpingo-oophorectomy was performed on 11 patients
and unilateral oophorectomy with or without hysterectomy on the remaining 6.
Two patients received radiation, one of whom is still living.
In our granulosa cell tumor group the mortality was 30%. This figure is
deceptive just as are the figures in many large series which show five-year cure
rates but fail to allow for late recurrence of the tumor. A summary of granulosa
and theca cell tumor cases seen at this clinic for the past 30 years is shown in Table I .
Case No. 13 represents one of the youngest patients with thecoma yet reported.
In 1950 no case of thecoma in a patient under age 16 had been reported, but by
1959 there were 5, one of whom was less than one year old. Our patient was
13 years of age, and onset of menses was at age 10. The menses were regular until
age 11 'A when the patient because of excessive bleeding was examined by a
physician. The patient was given "shots and pills" to control the menses but with
only partial success. The patient was first seen at this hospital because of excessive
bleeding, and the significant findings were development of secondary sex characteristics beyond that expected for her age and an adnexal mass considered to be a
granulosa cell tumor preoperatively. At operation a thecoma was found, and fat
stains were done to differentiate it from a "cellular fibroma". The patient is reported
without recurrence IV2 years after unilateral oophorectomy.
Case No. 2 is unusual because the patient had a recurrence of tumor in her
remaining ovary 18 years after the original tumor was removed and one year later
died of widespread metastases.
Case No. 9 represents a patient who had had a unilateral oophorectomy for
a granulosa cell tumor, and eight years later developed recurrence in the other
ovary. This ovary, and a granulosa cell tumor mass on the serosa of the colon
were excised, and a biopsy of an infiltrating lesion of the pelvic wall which also
proved to be granulosa cell was done. The patient received 2,400 r of deep x-ray
therapy and is living without further evidence of recurrence after five years.
DISCUSSION
The experience at this clinic with granulosa and theca cell tumors of the ovary
is similar to that reported in the literature. The number of "functional" tumors
found and the percentage of tumors clinically palpable are less than other authors
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Table I
HORMONE
PRESENTING SIGNS
CASE
ACTIVITY
AND SYMPTOMS
None
1. S. B. Symptoms & signs of P.I.D.—
age 33 chronic.
Unknown
2. C. H . Unknown.
age 51
3. M . K.
age 53
4. E. R.
age 43

Postmenopausal bleeding 1 yr.
D&C endo. hyperplasia.
Menorrhagia for 3 mos. Irreg.
menses 2 yrs.

Yes
Estrin
Yes
Estrin

5. R. A.
age 61
6. E. R.
age 62

Postmenopausal bleeding I wk. &
L. adnexal mass.
Postmenopausal bleeding 8 mos.
No adnexal mass. D&C—endo.
hyperplasia, bled after D&C.
Menomelrorrhagia for 10 mos. No
adnexal mass. Uterus 5 mos. preg.
gestation size.
Bilat. oophorectomy, because metastatic Ca of breast.
Oligomenorrhea for 3 yrs. Profuse
bleeding 2 wks. p.t.a. after menses
irreg. 3 mos.

Yes
Estrin
Yes
Estrin

7. T. L.
age 32
8. E. R.
age 48
9r"M. K.
age 39

10. V. A. Asymptomatic adnexal mass.
age 52
Ti7~M.Tr Postmenopausal bleeding for 2
age 54 mos. No adnexal mass.
l2r"R.T^ Postmenopausal bleeding 5 mos.
age 63 D&C. endo. hyperplasia, no mass.
13. C. T. Menarche age 10 yrs. Irreg. & proage 13 fuse at l l ' A . Adnexal mass felt.
14. A. G. Abdominal mass. No bleeding. Image 62 pression; fibroid or ovarian tumor.
15. M . M. Menorrhagia 1 yr. Impression:
age 47 fibroid.
16. V. A. Stress incontinence, no vag. bleedage 62 ing. R. Ovarian cyst.
17. C. G. Pelvic & back pain for 8 mos. L.
age 62 flank & lower abdominal pain for
2 mos.

Yes
Estrin
7
Estrin
Yes
Estrin

None

TREATMENT

PATHOLOGY

FOLLOW-UP

Hyst. Bilat. S&O.

Hyst. Bilat. S&O.

Micro, focus
Granulosa cell tumor
Granulosa
Recurrent 16 yrs. later
to pelvis & colon.
Granulosa cell tumor.

Hyst. & Unilat. S&O.

Granulosa cell tumor.

Hyst. Bilat. S&O.
2800 r of X-ray
Hyst. Bilat. S&O.

Granulosa cell tumor.

No data. Presented for
statistical reasons only.
Died 18 years after primary due to wide metastases.
Living and well in 1959,
no recurrence.
7 yrs. postop. carcinomatosis with Ca. R.
ovary as primiary.
Living and well in 1959,
no recurrence.
Living and well in 1959,
no recurrence.

Hyst. Bilat. S&O.

Granulosa cell tumor.

Had 3 full-term preg.
with normal infants. L
&W, no recurrence.
1 yr. postop. no recurBilat. Oophorectomy.
Granulosa cell tumor.
rence.
Hyst. & Unilat. S&O—1946. Granulosa cell tumor L. ovary, Had 2400 r Radiation
Recurrent granulosa cell tumor following 2nd surgery.
Other ovary removed 8 yrs,
R. ovary, colon, and pelvic wall. No evidence of recurlater due asympt.
pelvic mass.
rence 5 yrs. after radiation.
Hyst. Bilat. S&O.
Thecoma benign
Too recently done.
Unilat. oophorectomy
and appendectomy.

Granulosa cell tumor.

Yes
Estrin
Yes
Estrin
Yes
Estrin
None

Total hyst. Bilat. S&O.

Thecoma benign

Unknown.

Bilat. S&O, HYST,

Unknown.

Unilat. S&O.

Thecoma with
some granulosa cells
Thecoma, benign

Unilat. oophorectomy.

Thecoma, benign

No recurrence with reg.
menses 7 plus years.
No recurrence.

Yes
Estrin

Hyst. and R. oophorectomy.

Thecoma, benign

Unknown.

9

None

YEARS
SURVIVED

18
6 plus
alive
8
7 plus
alive
11 plus
alive
8 plus

alive
I plus
alive
13 plus
alive

7 plus
alive
15 plus
alive

Total hyst. R. oophorectomy.
Combination of thecal &
No recurrence.
3 plus
granulosa cell without definity.
Left previously.
alive
Anaplastic granulosa cell ca, Died in four monthsj Died in
Hyst. Bilat. S&O., CO"
not encapsulated—tube removed. due to metastases.
(6800 r)
four mos.
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report. The mortality rate compares with similar series and is high enough to
consider all granulosa-cell tumors as potentially malignant.
The results of unilateral versus bilateral oophorectomy with or without hysterectomy, as related to prognosis, is not as clear-cut in this series as it is in others.
However, bilateral surgery does appear to offer the best chance for survival.
Several cases reported elsewhere show unilateral, non-invasive and well-differentiated
granulosa cell tumors to have been found in patients 18-30 years of age. These
patients were treated by conservation of one ovary and later developed fatal recurrences.
The gynecologist who finds a granulosa cell tumor in a patient in the menstrual
age group must carefully consider further treatment indicated on the basis of all
available information. There is no clear-cut basis for the management of these
patients, and each must be given individual consideration. Some gynecologists
consider the patient's desire for future child-bearing as a basis for conservative
management while others feel that malignant or potentially malignant tumors should
be treated the same in all patients regardless of age.
SUMMARY
This report is a survey of 17 cases of granulosa cell and theca cell tumors
and represents a 30-year experience at this clinic. Three cases show unusual features.
Age is the chief factor considered in treatment. The mortality rate, number of
functional tumors found and surgical treatment are compared with similar series
appearing in the literature.
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